Q1 2024 Holdings
Filed 2024-05-15 | 77 holdings | $2.7B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Krystal Biotech Inc(KRYS) | COM | 501147102 | $268.4M | 1,508,250 | 9.8% |
| Amicus Therapeutics Inc(FOLD) | COM | 03152W109 | $156.2M | 13,257,286 | 5.7% |
| Immunome Inc(IMNM) | COM | 45257U108 | $120.7M | 4,889,554 | 4.4% |
| Scholar Rock Hldg Corp(SRRK) | COM | 80706P103 | $114.0M | 6,419,610 | 4.2% |
| Fate Therapeutics Inc(FATE) | COM | 31189P102 | $96.7M | 13,169,057 | 3.5% |
| Regenxbio Inc(RGNX) | COM | 75901B107 | $95.9M | 4,551,556 | 3.5% |
| Deciphera Pharmaceuticals in(DCPHEUR) | COM | 24344T101 | $83.3M | 5,296,643 | 3.1% |
| Kymera Therapeutics Inc(KYMR) | COM | 501575104 | $69.7M | 1,734,089 | 2.6% |
| ADC Therapeutics SA(ADCT) | SHS | H0036K147 | $68.6M | 15,269,217 | 2.5% |
| Stoke Therapeutics Inc(STOK) | COM | 86150R107 | $68.5M | 5,073,049 | 2.5% |
| Augmedix Inc(AUGX) | COM | 05105P107 | $67.0M | 16,380,327 | 2.5% |
| Nurix Therapeutics Inc(NRIX) | COM | 67080M103 | $65.9M | 4,483,016 | 2.4% |
| Biohaven LTD(BHVN) | COM | G1110E107 | $63.6M | 1,163,241 | 2.3% |
| Beam Therapeutics Inc(BEAM) | COM | 07373V105 | $62.1M | 1,879,617 | 2.3% |
| Zymeworks Inc(ZYME) | COM | 98985Y108 | $58.5M | 5,560,798 | 2.1% |
| Livanova PLC(LIVN) | SHS | G5509L101 | $58.1M | 1,037,780 | 2.1% |
| Shattuck Labs Inc(STTK) | COM | 82024L103 | $50.2M | 5,615,489 | 1.8% |
| ALX Oncology Hldgs Inc(ALXO) | COM | 00166B105 | $48.2M | 4,326,509 | 1.8% |
| Neurogene Inc(NGNE) | COM | 64135M105 | $47.6M | 935,252 | 1.7% |
| Akero Therapeutics Inc(AKRO) | COM | 00973Y108 | $47.0M | 1,858,702 | 1.7% |
| Absci Corporation(ABSI) | COM | 00091E109 | $46.9M | 8,253,316 | 1.7% |
| Pliant Therapeutics Inc(PLRX) | COM | 729139105 | $46.1M | 3,097,220 | 1.7% |
| Silence Therapeutics PLC(SLN) | ADS | 82686Q101 | $43.8M | 2,027,669 | 1.6% |
| Ideaya Biosciences Inc(IDYA) | COM | 45166A102 | $40.5M | 922,678 | 1.5% |
| 4D Molecular Therapeutics in(FDMT) | COM | 35104E100 | $40.2M | 1,261,427 | 1.5% |
| Annexon Inc(ANNX) | COM | 03589W102 | $39.5M | 5,503,190 | 1.4% |
| Boston Scientific Corp(BSX) | COM | 101137107 | $38.4M | 560,926 | 1.4% |
| Celldex Therapeutics Inc New(CLDX) | COM NEW | 15117B202 | $37.6M | 896,454 | 1.4% |
| Keros Therapeutics Inc(KROS) | COM | 492327101 | $36.6M | 552,506 | 1.3% |
| Catalent Inc(CTLTEUR) | COM | 148806102 | $35.7M | 632,464 | 1.3% |
| Immunovant Inc(IMVT) | COM | 45258J102 | $31.3M | 969,621 | 1.1% |
| Replimune Group Inc(REPL) | COM | 76029N106 | $30.5M | 3,729,983 | 1.1% |
| Abbott Labs(ABT) | COM | 002824100 | $29.8M | 262,371 | 1.1% |
| IGM Biosciences Inc(1K0) | COM | 449585108 | $29.6M | 3,072,478 | 1.1% |
| Align Technology Inc(ALGN) | COM | 016255101 | $28.6M | 87,255 | 1.1% |
| Cogent Biosciences Inc(COGT) | COM | 19240Q201 | $26.6M | 3,962,602 | 1.0% |
| 89Bio Inc(ETNBGBP) | COM | 282559103 | $26.4M | 2,264,566 | 1.0% |
| The Cigna Group(CI) | COM | 125523100 | $23.8M | 65,435 | 0.9% |
| Evolent Health Inc(EVH) | CL A | 30050B101 | $22.3M | 679,172 | 0.8% |
| Verve Therapeutics Inc | COM | 92539P101 | $21.3M | 1,604,515 | 0.8% |
| Entrada Therapeutics Inc(TRDA) | COM | 29384C108 | $18.2M | 1,283,735 | 0.7% |
| HCA Healthcare Inc(HCA) | COM | 40412C101 | $17.5M | 52,487 | 0.6% |
| Elevance Health Inc(ELV) | COM | 036752103 | $16.2M | 31,223 | 0.6% |
| Ardelyx Inc(ARDX) | COM | 039697107 | $16.0M | 2,194,560 | 0.6% |
| Boundless BIO Inc(BOLD) | COM | 10170A100 | $15.9M | 1,114,034 | 0.6% |
| Stryker Corporation(SYK) | COM | 863667101 | $15.5M | 43,246 | 0.6% |
| Gritstone BIO Inc(2JQ) | COM | 39868T105 | $14.8M | 5,755,075 | 0.5% |
| Prime Medicine Inc(PRME) | COM | 74168J101 | $14.5M | 2,074,350 | 0.5% |
| Icon PLC(ICLR) | SHS | G4705A100 | $12.4M | 36,949 | 0.5% |
| Progyny Inc(PGNY) | COM | 74340E103 | $12.2M | 320,864 | 0.4% |